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Canonical Wnt signaling has been implicated in the
regulation of hematopoiesis. By employing a Wnt-
reporter mouse, we observed that Wnt signaling is
differentially activated during hematopoiesis, sug-
gesting an important regulatory role for specific
Wnt signaling levels. To investigate whether canon-
ical Wnt signaling regulates hematopoiesis in a
dosage-dependent fashion, we analyzed the effect
of different mutations in the Adenomatous polyposis
coli gene (Apc), a negative modulator of the canon-
ical Wnt pathway. By combining different targeted
hypomorphic alleles and a conditional deletion allele
of Apc, a gradient of five different Wnt signaling
levels was obtained in vivo. We here show that
different, lineage-specific Wnt dosages regulate
hematopoietic stem cells (HSCs), myeloid precur-
sors, and T lymphoid precursors during hemato-
poiesis. Differential, lineage-specific optimal Wnt
dosages provide a unifying concept that explains
the differences reported among inducible gain-of-
function approaches, leading to either HSC expan-
sion or depletion of the HSC pool.
INTRODUCTION
Hematopoiesis, i.e., the production of blood cells, is fully depen-
dent on a rare population of hematopoietic stem cells (HSCs) that
have the capacity to self-renewanddifferentiate into all blood cell
lineages. This process is strictly regulated by signals provided by
the surrounding microenvironment of the different organs where
hematopoiesis occurs (Wilson and Trumpp, 2006). Although
canonical Wnt signaling is recognized as one of the signaling
cascades implicated in the regulation of HSC function as well
as in other stages during hematopoiesis, its specific functional
role has not been completely understood and is to date a matter
of controversy (Blank et al., 2008; Staal et al., 2008).
Activation of theWnt pathway occurs upon binding of a soluble
Wnt protein to amembrane-associated receptor and leads to the
disruption and inhibition of a protein complex responsible for
the phosphorylation and breakdown of b-catenin. Inhibition ofCthis so-called destruction complex, composed of the tumor
suppressor adenomatous polyposis coli (Apc), the Ser-Thr
kinases glycogen synthase kinase 3b (Gsk-3b) and casein
kinase I (CK-I), and the scaffold and tumor suppresor protein
Axin, results in stabilization and accumulation of b-catenin.
Upon its intracellular stabilization, b-catenin subsequently trans-
locates to the nucleus where, together with the Tcf-Lef family of
transcription factors, it activates a Wnt-controlled gene expres-
sion program. Besides the canonical Wnt pathway, which is
mediated via b-catenin, other noncanonical Wnt signaling routes
have been described, for instance those mediated by calcium
signaling or c-Jun N-terminal kinases (JNK) (Staal et al., 2008;
Reya and Clevers, 2005).
Canonical Wnt signaling has been implicated in the self-
renewal of various stem cell compartments in the gut, mammary
gland, skin, and embryonic stem cells (ESCs). Notably, Wnt
signaling influences the capacity of ESCs to differentiate into
the three main germ layers (ectoderm, mesoderm, and definitive
endoderm) in a dosage-dependent fashion (Kielman et al., 2002).
In addition, different levels of activation of the pathway confer
different degrees of tumor susceptibility in different tissues
(Fodde et al., 2001; Smits et al., 1999). These Wnt dosage-
dependent effects also seem to hold true for adult self-renewing
tissues such as gut and skin, although the underlying cellular and
molecular mechanisms still remain poorly understood (Gaspar
and Fodde, 2004; Silva-Vargas et al., 2005).
In the hematopoietic system, a role for Wnt signaling was first
demonstrated during T cell development in the thymus where it
provides proliferation signals to immature thymocytes (reviewed
in Rothenberg et al., 2008; Staal et al., 2008). Indeed, Tcf1 defi-
ciency affects the highly proliferative stages double-negative 2
(DN2) and DN4 (Schilham et al., 1998; Verbeek et al., 1995),
and conditional deletion of b-catenin inhibits T cell development
at b-selection checkpoint (DN3) (Xu et al., 2003). Furthermore,
activation of the pathway by in vivo stabilization of b-catenin
resulted in thymocyte development without the requirement of
pre-TCR signaling and impaired transition from double-negative
(DN) to double-positive (DP) stages of T cell development
(Gounari et al., 2001). Besides regulating T cell development in
the thymus, Wnt signaling was also shown to play a role in the
regulation of HSC function. We and others recently showed
that Wnt is necessary for normal HSC function by employing
eitherWnt3a-deficient mice (Luis et al., 2009), by overexpressing
the Wnt-negative regulator DKK1 in osteoblastic stem cell nicheell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc. 345
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Figure 1. In Vivo Measurement of Canonical
Wnt Signaling Activity throughout Hematopoietic
Development
Activation of the canonical Wnt signaling pathway was
measured using the Axin2/conductinLacZ/+ Wnt-reporter
mice by FACS. Quantification of the mean fluorescence
intensity (MFI) (A, B) and frequency (C, D) of the LacZ+
populations for each subset in the BM (A, C) and in the
thymus (B, D). Littermate mice not carrying the reporter
transgene (Axin2/Conductin+/+) were used to define the
LacZ population. For each subset, MFI of the LacZ+
population was normalized for the MFI of corresponding
LacZ population (MFI LacZ+/MFI LacZ) in order to
correct for differences in background staining between
different hematopoietic populations. Data represent
results from six Axin2/conductinLacZ/+ mice and three
Axin2/Conductin+/+ control mice, from two independent
experiments. Error bars represent standard error of the
mean (SEM). ND, not detected (below background stain-
ing in nonreporter mice). *p < 0.05 and **p < 0.01. The
different hematopoietic populations were defined as
described in Table S1 and the gating strategy is shown in
Figures S2 and S3.
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Differential Wnt Signaling during Hematopoiesis(Fleming et al., 2008), or by Vav-Cre-mediated conditional dele-
tion of b-catenin (Zhao et al., 2007). However Mx-Cre-mediated
deletion of b-catenin (Cobas et al., 2004) or b- and g-catenin
simultaneously (Jeannet et al., 2008; Koch et al., 2008) did not
affect hematopoiesis, probably because of the fact that Wnt
signaling was not completely abolished in thesemodels (Jeannet
et al., 2008). Besides these approaches to inhibit Wnt signaling,
gain-of-function approaches to activate the pathway in HSCs
were perfomedwith conflicting results. Stabilized forms of b-cat-
enin resulted in either enhancement of HSC function andmainte-
nance of an immature phenotype (Baba et al., 2005; Malhotra
et al., 2008; Reya et al., 2003; Willert et al., 2003) or exhaustion
of theHSCpool followed by failure of repopulation in transplanta-
tion assays (Kirstetter et al., 2006; Scheller et al., 2006). These
differences may be explained by the different levels of Wnt
pathway activation (Suda and Arai, 2008; Trowbridge et al.,
2006), resulting from the different approaches employed and/or
the interference of other signals in the context of Wnt activation
(Goessling et al., 2009; Huang et al., 2009; Nemeth et al., 2007).
Here, we studied the effect of different dosages of Wnt signal-
ing activation on HSC self-renewal and differentiation capacity.
To this aim, we used mouse models carrying specific hypomor-
phic mutations at theApc gene resulting in specificWnt signaling
dosages (Fodde and Smits, 2001; Robanus-Maandag et al.,
2010). The Apc gene encodes for a multifunctional protein that
is most known for binding and downregulating b-catenin. By
employing this in vivo approach, we show that differential,
lineage-specific, optimal Wnt dosages regulate HSC, myeloid
precursors, and T lymphoid precursors during hematopoiesis.
RESULTS
The Canonical Wnt Signaling Pathway Is Differentially
Activated during Hematopoiesis
In order to determine the activation status of the canonical Wnt
signaling pathway during hematopoiesis, we employed the346 Cell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc.well-established Axin2LacZ Wnt reporter mice (Jeannet et al.,
2008; Jho et al., 2002; Lustig et al., 2002). In these mice,
a LacZ cassette is inserted in-frame with the start codon of the
ubiquitous Wnt target gene Axin2/Conductin, allowing analysis
of the Wnt/b-catenin pathway by measuring b-galactosidase
(LacZ) activity in vivo. Incubation of Axin2LacZ/+ bone-marrow
(BM) cells with increasing concentrations of the Wnt signaling
activator LiCl resulted in differential LacZ activity, showing that
the reporter is sensitive to different levels of Wnt activation
(see Figures S1A and S1B available online). Because Axin2 is
also a negative regulator of the Wnt signaling pathway, we also
verified whether Axin2 haploinsufficiency would affect the hema-
topoietic system. In line with data from other developmental
systems, the hematopoietic system of the Axin2+/LacZ mice
was found to be overall normal when compared to mice not
carrying the reporter transgene (Axin2+/+) (Figures S1C–S1H).
Canonical Wnt signaling was active in most of the subsets
analyzed (Figures 1, S2, and S3). A remarkable difference was
observed in the different subsets in BM (Figures 1A and S2)
compared to thymus (Figures 1B and S3). Thymocytes displayed
higher levels of Wnt activation than cells in BM. Despite the
absence or much reduced Wnt signaling levels in more mature
myeloid and B cell subsets, the most immature progenitors
from both these lineages undergo Wnt signaling activation,
which is particularly high in the Pre/Pro-B subset. In the thymus,
besides the generally higher activation levels, immature single-
positive (ISP), DP, and SP stages showed a further signaling
increase, in comparison to the double-negative (DN) subsets.
Of notice, early thymic progenitors (ETP) showed a significantly
lowerWnt activity, suggesting that only after entering the thymus
do the T cell progenitors receive stronger Wnt signals. This is in
agreement with the reported high expression of several Wnt
genes in thymic stromal cells (Pongracz et al., 2003; Weerkamp
et al., 2006).
Notably, the higher Wnt activity in the thymus was also re-





Figure 2. Targeted Mutations of Apc Allow Modulation of Canonical Wnt Signaling in the Hematopoietic System
(A) Schematic representation of the Apc gene and the proteins expressed by the mutated Apc alleles. Different functional domains inside Apc exon 15 are
depicted.
(B) Retroviral construct encoding for the Cre recombinase and GFP reporter genes, used for ex vivo deletion of the Apc15lox allele.
(C and D) Analysis of deletion efficiency of the Apc15lox allele at DNA (C) and mRNA (D) levels. Analysis was performed on GFP+ sorted cells, 3 days after
transduction, by PCR and qRT-PCR, respectively. Floxed/nondeleted band is no longer detected after transduction, indicating that deletion was virtually
complete. Data represent three independent experiments. Unt, untransduced.
(E) Expression analysis of the Wnt-reporter gene Axin2, carried out in transduced (GFP+) LSKs frommice with the indicated combinations of mutated and normal
Apc alleles. Results represent four independent experiments. Error bars represent SEM; p < 0.05.
(F) Expression analysis of Axin2 in transduced LSKs from Ctnb1(Dex3)Fl/+ mice. Results from three different mice. Error bars represent standard deviations (SD).
Cell Stem Cell
Differential Wnt Signaling during Hematopoiesiscompared to the hematopoietic subsets in the BM (Figures 1C,
1D, S2, and S3). Analysis of Axin2 expression at molecular level
by qRT-PCR similarly showed a higher expression in DN and DP
thymocytes, in comparison to LSK cells in BM (Figure S3C).
Hypomorphic Apc Mutations Allow Modulation
of Canonical Wnt Signaling Levels
in the Hematopoietic System
The differential Wnt signaling activity in distinct hematopoietic
lineages suggested that specific levels of pathway activation
could differentially affect hematopoiesis. To investigate whether
Wnt signaling regulates HSC self-renewal and differentiation
in a dosage-dependent fashion, we analyzed the effects of differ-
ent targeted mutations in the Apc gene. With combinations of
two different hypomorphic alleles and a conditional deletion
allele of Apc, a gradient of five different levels of Wnt signaling
in vivo was obtained. Apc1572T and Apc1638N alleles were previ-
ously generated by targeting amino acid residues 1572 and
1638 on exon 15, which encodes nearly all Wnt regulatory
sequences in the Apc gene (Fodde et al., 1994; Smits et al.,
1999). The Apc1572T allele encodes for a truncated protein en-
compassing all b-catenin binding domains, three of the seven
b-catenin degradation repeats, but none of the Axin/conductin
binding (SAMP) motifs. The Apc1638N allele encodes for a slightly
longer protein (encompassing only one SAMP motif). This muta-Ction results in an unstable mRNA, leading to the very low expres-
sion of a truncated Apc protein (approximately 2% of the wild-
type protein level) (schematically depicted in Figure 2A). Hence,
these targeted mutations result in different levels and lengths
of truncated Apc proteins, consequently leading to different
levels of Wnt pathway activation (Fodde and Smits, 2001; Gas-
par and Fodde, 2004). Because homozygosity for these Apc
mutations leads to early embryonic lethality (Fodde et al.,
1994; Gaspar et al., 2009), we combined them with a conditional
Apc mutant allele (Apc15lox) where Apc exon 15 is flanked by
LoxP sequences which, upon Cre-mediated recombination,
lead to an Apc-null allele (Robanus-Maandag et al., 2010). The
two hypomorphic alleles, the conditional deletion allele, and
the wild-type Apc allele were then bred in order to obtain differ-
ent compound heterozygous mouse lines providing a gradient of
Wnt signaling activation above normal. Deletion of Apc exon 15
within the Apc15lox allele was performed ex vivo by using the
retroviral Cre gene transduction system (Figure 2B; Loonstra
et al., 2001; Tadokoro et al., 2007). LinSca1+c-Kit+ (LSK)
cells, which are highly enriched for HSCs, were isolated from
the BM of mice carrying different Apc allele combinations and
transduced with pMSCV-Cre-IRES-GFP retrovirus (Figure S4A).
LSK cells fromwild-typemice (Apc+/+) transduced with the same
viral construct were employed as control for all experiments.
Three days after transduction, deletion was virtually completeell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc. 347
A B Figure 3. Mild to Intermediate Increase of Wnt
Signaling Activity Enhances Myeloid Differentia-
tion and Confers an Immature Phenotype
Methylcellulose colony-forming assays performed with
sorted GFP+ LSKs from the different genotypes.
(A) Total number (*p < 0.05) and relative frequency of
the different colonies counted after 9–10 days of culture.
Frequency of GM colonies is significantly increased in
Apc15lox/+ in comparison to Apc+/+ (p < 0.01). Frequency
of M colonies is significantly increased in Apc15lox/+ in
comparison to Apc+/+ (p < 0.05) and in Apc15lox/1572T in
comparison to Apc15lox/+ (p < 0.05).
(B) c-Kit expression in total colonies from each condition.
Numbers represent frequency of c-Kit+ cells. Shaded
histogram represent Apc+/+ (5.6% c-Kit+ cells). Results are
representative of three independent experiments. Error
bars represent SEM. CFU, colony forming unit; M,
macrophage; G, granulocyte; GM, granulocyte-macro-
phage; Mix, mixed (containing at least three different types
of cells); BFU-E, burst forming unit-erythrocytes.
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Differential Wnt Signaling during Hematopoiesisin GFP-positive cells, as shown both at the DNA (Figure 2C) and
mRNA (Figure 2D) levels.
To test whether the different combinations of Apc alleles lead
to different levels of Wnt signaling activation in HSCs, Axin2
expression was determined by qRT-PCR on GFP+ cells. The
Apc15lox allele in heterozygosity (Apc15lox/+) or in combination
with the Apc1572T allele (Apc15lox/1572T) leads to a mild (2-fold)
or intermediate (4-fold) increase of activation of theWnt signaling
pathway, respectively, when compared to wild-type levels (Fig-
ure 2E). The combination of Apc15lox and Apc1638N alleles
(Apc15lox/1638N) results in a high activation level of the pathway
(22-fold), which is in the same range of activation obtained with
conditional deletion of b-catenin exon-3 (Ctnb1Dex3; 20-fold),
leading to its constitutive stabilization (Figures 2E and 2F;
Harada et al., 1999; Kirstetter et al., 2006; Scheller et al.,
2006). Finally, the Apc15lox allele when bred to homozygozity
(Apc15lox/15lox) results in an extremely high (72-fold) activation
of the Wnt signaling pathway. In agreement, the increased
expression of Axin2 correlated with increased accumulation of
b-catenin (Figures S4B and S4C). No evidence of significantly
altered proliferation or survival was observed after 3 days of
culture (Figure S4D). Hence, by combining three different
targeted Apc mutant alleles, a gradient of five different levels
of Wnt activation was obtained, enabling us to study Wnt
dosage-dependent effects. To this aim, deleted GFP+ LSKs
from mice carrying the above genotypes were employed for
in vivo and in vitro assays.
Intermediately Increased Levels of Wnt Signaling
Activation Enhance Clonogenicity and Myeloid
Differentiation
We used methylcellulose colony-forming assays to determine
clonogenic and differentiation potential of LSK cells from the
different Apc mouse lines. Apc15lox/+ and Apc15lox/1572T GFP+
LSKs caused an increase of approximately 2-fold in the number
of colonies, in comparison to Apc+/+ GFP+ LSKs (p < 0.05). This
was mainly due to an increase in granulocytic-monocytic (GM)
and monocytic (M) colony-forming units (CFU), suggesting that
mild to intermediate levels of Wnt signaling activation results in
increased clonogenicity and myeloid differentiation potential.348 Cell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc.Notably, a strong reduction in the number of colonies was
observed with the higher levels of Wnt activation (Figure 3A).
Importantly, analysis of c-Kit expression in the colonies revealed
that increasing Wnt signaling activity results in increased
frequency of c-Kit+ cells and, therefore, leads to the mainte-
nance of an immature phenotype (Figure 3B). PCR analysis on
genomic DNA from day 9 colonies revealed efficient deletion of
the floxed exon 15 (Figure S6A). Moreover, the gradient of Wnt
signaling activation was maintained during culture as deter-
mined by Axin2 expression (data not shown).
Only Mildly Increased Wnt Signaling Levels Enhance
HSC Repopulation Capacity
To quantitatively determine the effects of increasing levels ofWnt
signaling on HSC function, we performed competitive limiting-
dilution transplantation assays via the CD45.1/CD45.2 system.
Mildly increased activation of the Wnt signaling pathway, corre-
sponding to the haploinsufficient Apc15lox/+ genotype, resulted
in a 6-fold increase in the frequency of repopulating cells, in
comparison to the wild-type condition (Apc+/+ GFP+ LSKs) (Fig-
ure 4A). The frequency of competitive repopulating units (CRU)
increased from 1/40371 (Apc+/+) to 1/6717 (Apc15lox/+), 12 weeks
after transplantation (p = 0.009). In contrast, intermediate
(Apc15lox/1572T) and higher (Apc15lox/1638N and Apc15lox/15lox)
levels of Wnt signaling activation resulted in a total impairment
in repopulation capacity (Figures 4A and 4B). The increased
repopulation capacity conferred by mildly increased Wnt levels
was also observed by an approximately 3-fold increase in the
level of chimerism in mice transplanted with Apc15lox/+ cells,
when compared to Apc+/+ cells, 12 weeks after transplantation
(p = 0.011) (Figures 4C and 4D). Analysis of the HSC compart-
ment in the BM of the recipient mice also showed an increase
in the number of GFP+ LSKs (p = 0.06, Figures 4E and 4F).
Furthermore, secondary transplantation of these cells showed
efficient repopulation of lethally irradiated CD45.1 recipients.
Twelve weeks after transplantation in secondary recipients, the
advantage showed by the Apc15lox/+ cells could still be observed
in total BM chimerism and within the HSC compartment (Figures
S5A and S5D), thus indicating that mildly increased levels of
activation enhance long-term repopulation capacity. To obtain
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Figure 4. Mildly Increased Wnt Signaling Enhances HSC Function
(A) Limiting dilution analysis of the repopulating ability of transduced (GFP+) LSKs from the different genotypes specified. Four to six mice were transplanted for
each dosage of cells (7, 10, 30, and 403 103) per genotype in a total of 59 initial recipients. The CRU frequency increased from 1/40,371 in the Apc+/+ condition
(95% confidence interval for mean: 1/22,388–1/72,798) to 1/6,717 in the Apc15lox/+ condition (95% confidence interval for mean: 1,486–1/10,059) (p = 0.009).
Dosages resulting in 100% of mice repopulated were not plotted.
(B) Repopulation efficiency analyzed in the peripheral blood ofmice transplantedwithApc+/+,Apc15lox/+,Apc15lox/1572T,Apc15lox/1638N, andApc15lox/15lox 12weeks
after transplantation.
(C–F) Cre-IRES-GFP-transduced Apc+/+ and Apc15lox/+ LSK cells were transplanted into lethally irradiated Ly5.1 recipients (without sorting of GFP+ cells). Data
represent six mice in each group. Error bars represent SD.
(C and D) Repopulation efficiency analyzed in peripheral blood of recipient mice 12 weeks after transplantation (p = 0.023).
(E) Analysis of the HSC compartment of recipient mice. LSKs were gated and analyzed for CD45.2 and GFP expression.
(F) Frequency of CD45.2+GFP+ LSK cells in the BM of the recipient mice (p = 0.05).
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outcomes obtained with different Wnt dosages, we assessed
expression of a number of HSC self-renewal-related genes that
may also represent downstream Wnt targets (Figure S5E). Acti-
vation of b-catenin was previously shown to lead to the downre-
gulation of the self-renewal genes Hoxb4 and Cdkn1a (Kirstetter
et al., 2006; Scheller et al., 2006). Accordingly, intermediate and
high levels of Wnt activity resulted in downregulation of these
genes. Notably, the same Hoxb4 and Cdkn1a genes displayed
normal expression levels in cells with mildly increased Wnt
pathway activation (Apc15lox/+) and enhanced HSC function,
suggesting that, in contrast to higher Wnt dosages, relatively
low levels preserve self-renewal capacity. Because Myc activity
was recently shown to be critical for HSC function (Laurenti et al.,
2008), we also analyzed expression of c-Myc and N-Myc genes.
Although no differences in c-Myc expression were observed,
increasing levels of Wnt signaling resulted in a proportional
downregulation of N-Myc. In addition, the expression of
Fibronectin (Fn1), an extracellular matrix component known toCmediate interactions of HSCs with the niche (Williams et al.,
1991) and an established Wnt target gene (Staal et al., 2004),
was upregulated with increasing dosages of Wnt signaling. A
trend toward upregulation in a Wnt dosage-dependent fashion
was also observed for Cd44 and Cxcr4 but this trend did not
reach statistical significance (Figure S5E).
In addition to enhanced HSC function and in agreement
with the in vitro methylcellulose colony assays, an increase in
myeloid differentiation was also observed (Figures S6B–S6H).
The myeloid compartment in BM of mice transplanted with
Apc15lox/+GFP+ was significantly enlarged (p = 0.041), and this
was mainly due to an effect in the immature CD11b+F4/80
myeloid cells (p = 0.035; Figure S6C). Analysis of the early
myeloid progenitor subsets showed that in the Apc15lox/+GFP+,
the GMP compartment was expanded (p = 0.08) whereas
CMPs appeared with a frequency comparable to the wild-type
control (Figure S6D). This increase was also reflected in absolute
numbers of myeloid cells (Figure S6E). Despite an increase in
myeloid progenitors in BM, this increase was not reflected inell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc. 349
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Differential Wnt Signaling during Hematopoiesisblood (Figure S6F). This is in agreement with the reduction in
myeloid progenitors without affecting terminal myeloid differen-
tiation, observed in Wnt3a/ mice (Luis et al., 2009). Accord-
ingly, no signs of a MDS-like phenotype were observed in these
mice. Although an impairment in repopulation was observedwith
intermediate levels of Wnt activation (Apc15lox/1572T), the remain-
ing detectable donor cells at 8 weeks posttransplantation were
skewed toward myeloid development (68% in Apc15lox/1572T
condition comparing to 46% in Apc15lox/+; p = 0.029; Figures
S6G and S6H). This indicates that an intermediate increase of
Wnt signaling levels also confers in vivo advantage for myeloid
development. It is an interesting possibility that the expansion
of the myeloid compartment may also result from a bias in differ-
entiation toward the myeloid lineage (‘‘myeloid skewing’’) at the
expense of lymphoid differentiation, with mild to intermediate
levels of Wnt signaling activation.
T Cell Development Is Enhanced by Higher Wnt
Signaling Levels
Because HSCs with the highest levels of Wnt signaling fail to
reconstitute mice, this approach does not allow the study of
the effect of these same levels on T cell development in vivo.
In order to study Wnt dosage-dependent effects on T cell devel-
opment in vitro, we cocultured GFP+ LSK together with the OP9
BM-derived stromal cell line expressing the Notch ligand Delta1
(Schmitt and Zu´n˜iga-Pflu¨cker, 2002) meant to induce a T cell
differentiation program (Jaleco et al., 2001). Mild Wnt signaling
increase (Apc15lox/+) had no additional effect on T cell develop-
ment over wild-type levels. Notably, intermediate levels of Wnt
activation (Apc15lox/1572T) result in enhanced T cell development,
as observed by an approximately 3-fold increase in the
frequency of DN4 cells and a 10- to 15-fold increase in DP and
SP CD4+ T cells (Figures 5A and 5B). In contrast, very high Wnt
signaling activation results in a partial arrest of T cell develop-
ment at DN3 stage (Figure 5A), consistent with the reduced total
cell numbers in culture (Figure 5B).
Previously, the Wnt and Notch signaling pathways were
shown to cross-talk (Duncan et al., 2005). Therefore, we
analyzed the effect of Notch signaling activation on Wnt activity
by determining Axin2 expression levels on GFP+CD45+ cells
after coculture on OP9-DL1 versus OP9-GFP. qRT-PCR analysis
of Hes1 and Axin2 expression showed that Notch signaling was
efficiently activated in all conditions (Figure 5C) and the gradient
of Wnt signaling activation conferred by the different Apc alleles
combinations was maintained in the presence of Notch signals
(Figure 5C).
To investigate whether the same Wnt dosage-dependent
effects are observed in vivo, the different Apc mutant mouse
lines were crossed with Lck-Cre mice. Lck-Cre allowed condi-
tional deletion of the Apc15lox allele starting at the DN2 stage
and was virtually complete at the DN3 stage (Figure 6A). Analysis
of Axin2 expression on DN3 thymocytes confirmed the Wnt
dosage effect of the differentApc alleles in DN3 thymocytes (Fig-
ure S7). In agreement with the in vitro data, only intermediateWnt
signaling activity (Apc15lox/1572T) enhanced T cell development.
Furthermore, although mild levels of activation (Apc15lox/+) had
no effect on T cell development, high (Apc15lox/1638N) and very
high (Apc15lox/15lox) Wnt signaling activity resulted in accumula-
tion of CD44CD25+ and CD44CD25int DN3 cells (Figures 6B350 Cell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc.and 6C). Similar to what was reported for the conditional stabili-
zation of b-catenin (Gounari et al., 2001), high and very high Wnt
activity resulted in impaired Tcrb gene rearrangements (Fig-
ure 6D), and cells without Tcrb rearrangements could escape
the b-selection checkpoint and progress to the DP and SP
stages. In contrast, intermediate levels of Wnt signaling
(Apc15lox/1572T) allowed cells to progress through DN3 stage
and form DN4 thymocytes with normal expression levels of
Tcrb in the majority of the mice (Figures 6B–6D). Only one out
of six mice showed a slightly reduced frequency of cells with
Tcrb expression (56% Tcrb+ cells in comparison to 75.3% in
the wild-type DN4 cells). Notably, an accumulation of CD44+
CD25 cells (usually defined as DN1) was also observed. An
increase in DN1 cells is unexpected because Lck-Cre-mediated
deletion occurs only at the DN2-DN3 stages. Further character-
ization of this population revealed that they do not express
c-Kit, TCR-gd, or other lineage markers, thus excluding the
possibility that these cells represent thymic progenitors or other
alternative lineages, such as gd-T cells or NK cells. Instead,
these cells express intracellular Tcrb (iTcrb) and show deletion
of the Apc15lox allele (data not shown), suggesting that they are
DN4 cells with CD44 upregulation reminiscent of DN1 cells.
CD44 is a well-established Wnt target gene (Wielenga et al.,
1999). Therefore, for absolute quantification purposes, DN4 cells
were defined as CD25iTcrb+ in the Apc15lox/1572T mice. In this
way, a 5-fold increase in the numbers of DN4 cells was observed
in the thymus of Lck-Cre:Apc15lox/1572T mice, in comparison to
the Lck-Cre:Apc+/+ control mice (Figures 6B and 6C), indicating
that intermediate levels of Wnt signaling favor the immature DN
stages. Nevertheless, thymi with intermediate, high, and very
high levels of Wnt signaling showed decreased numbers of DP
thymocytes (2-, 4-, and 38-fold, respectively). This reduction
was more pronounced with the higher levels of activation of
the Wnt signaling pathway (Figure 6C). These results indicate
that within the T cell lineage, differential effects of Wnt signaling
strength can be observed, namely the expansion of the DN
subpopulations favoring higher levels of Wnt signaling than the
DP and SP stages.
DISCUSSION
In this study, we made use of combinations of different Apc-
mutant mouse strains, resulting in a gradient of five different
levels of Wnt signaling activation in vivo. A differential optimum
of Wnt signaling activation was observed in HSCs, myeloid
progenitors, and early (DN) thymocytes (Figure 7). Moreover,
analysis of the Axin2LacZ Wnt-reporter mouse showed that the
activity of theWnt signaling pathway is regulated during hemato-
poiesis, with thymocytes exhibiting higher levels of pathway acti-
vation compared to HSC and other BM progenitor subsets.
Canonical Wnt signaling was previously shown to regulate
HSC function (Fleming et al., 2008; Kirstetter et al., 2006; Luis
et al., 2009; Reya et al., 2003; Scheller et al., 2006). However,
different strategies to achieve activation of the pathway resulted
in contrasting outcomes, leading to either enhanced repopula-
tion capacity or depletion of the HSC pool (Staal et al., 2008).
Here, by using the different Apc mutant mouse lines, we
observed that only a mild increase in Wnt signaling activation
enhanced HSC function. Importantly, this mild Wnt activation
AB C
Figure 5. Intermediately Increased Wnt Activation Enhances T Cell Development
(A) GFP+LSKswith different levels ofWnt activationwere cultured for 13 days onOP9-DL1. Analysis was performed inside aCD45 gate in order to exclude stromal
cells.
(B) Total cell numbers obtained after 13 days of coculture with OP9-DL1. Results are from three independent experiments. p < 0.02.
(C) Transduced LSK cells frommicewith the differentApc alleles combinationswere cocultured for 24 hr with OP9-DL1 or OP9-GFP as control. qRT-PCRanalysis
of Hes1 and Axin2 expression was performed on sorted GFP+CD45+ cells.
Results are from two independent experiments. p < 0.05. Error bars represent SEM.
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Differential Wnt Signaling during Hematopoiesisleads to an increase in the number of CRUs and a subsequent
increase in chimerism. In contrast, and in agreement with
previous studies where in vivo conditional approaches to either
stabilize b-catenin (Kirstetter et al., 2006; Scheller et al., 2006)
or to delete Apc (Qian et al., 2008) in hematopoietic cells were
employed, intermediate and higher levels of activation of the
pathway impaired HSC repopulation capacity. Furthermore,
although intermediate and higher levels of Wnt activity lead
to downregulation of the HSC self-renewal genes Hoxb4 and
Cdkn1a in agreement with a reduced repopulation capacity,
a mild activation of the Wnt pathway does not influence the
expression of these genes. This suggests that, at lower activity
levels, Wnt signaling does not impair HSC function. In addition,Cupregulation of Fn1, previously shown to mediate adhesion of
HSCs to the niche (Williams et al., 1991), was regulated in a
Wnt-dependent fashion. A trend for upregulation of Cd44 and
Cxcr4 was also observed but this did not reach statistical signif-
icance. Cxcr4 upregulation with high levels of Wnt activation
suggests that differences in Cxcr4-mediated HSC homing
cannot explain the impairment in HSC reconstitution. Therefore,
we here provide experimental evidence for a correlation between
Wnt signaling strength and different outcomes in HSC function,
as previously speculated to exist (Suda and Arai, 2008; Trow-
bridge et al., 2006). Given that HSCs have enhanced activity
only with lower levels of Wnt activity, it is likely that the remaining
Wnt signaling still present in b-catenin/g-catenin conditionalell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc. 351
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Figure 6. In Vivo Analysis of Wnt Signaling Dosage-Dependent Effects on T Cell Development via Lck-Cre-Mediated Deletion
(A) DN2, DN3, and DN4 thymocytes from Apc15lox/+:Lck-Cre mice were sorted and the DNA was analyzed for deletion of the Apc exon15 allele by PCR. Deletion
was virtually complete at DN3 stage.
(B) Immunophenotypical analysis of the different thymocyte populations.
(C) Thymic cellularity and absolute quantification of different thymocyte subsets. Data represent the mean from three independent experiments with a total of
six to seven mice per group. *p < 0.05; **p < 0.01. Error bars represent SEM.
(D) Analysis of intracellular Tcrb expression on electronically gated DN4 thymocytes. Nonshadowed histograms represent Tcrb expression on Apc+/+:Lck-Cre
mice (75.3% iTcrb+ cells). Data are representative of three independent experiments.
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Differential Wnt Signaling during Hematopoiesisdeletion mouse models (Jeannet et al., 2008) is sufficient to
sustain normal hematopoiesis. In accordancewith a requirement
of Wnt signaling for normal HSC function, Wnt3a deficiency (Luis
et al., 2009) and overexpression of the Wnt inhibitor Dkk1 in the
HSC niche (Fleming et al., 2008), both resulting in the absence of
canonical Wnt signaling (Luis et al., 2010), lead to impaired LT-
HSC repopulation capacity. Recent studies using ApcMin/+
mice (Goessling et al., 2009; Lane et al., 2010) or a shRNA
approach to knock down Gsk3b (Huang et al., 2009) showed
similarly increased HSC repopulation efficiency. However,
decreased LT repopulation capacity in secondary transplanta-
tion assays was observed in two of these studies. In our studies,
a mildWnt activation also favored LT reconstitution in secondary
recipients. These differences may be explained by slight varia-
tions in the different Wnt levels achieved or, alternatively, by
a sustained activation of the pathway having a harmful effect
on HSCs. Recently, the Apcmin mutation in heterozygosity was
shown to lead to an environmentally determinedMDS/myelopro-
liferative phenotype (Lane et al., 2010). In agreement with
this study, no signs of MDS-like phenotype were observed in
mice transplanted with Apc15lox/+ deleted HSCs, because cells352 Cell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc.carrying the Apc15lox mutation were transplanted in a WT envi-
ronment. Besides the remaining Wnt signaling activity found in
some of the loss-of-function approaches employed, differences
in Wnt signaling strength requirements between adult and
fetal hematopoiesis may also account for the different results
observed. In fact, given that fetal liver hematopoiesis is highly
dependent on Wnt signals (Luis et al., 2009; Zhao et al., 2007),
in particular on Wnt3a (Luis et al., 2009, 2010), it is possible
that fetal HSCs are associated with higher Wnt activity than
adult HSCs. We here discuss our findings in the context of
dosage because this provides a mechanistic explanation for
the observed effects, but it is likely that other factors also play
a role in differences between fetal and adult hematopoiesis.
Wnt signaling was previously shown to induce and/or maintain
an immature phenotype on hematopoietic progenitors (Baba
et al., 2005; Malhotra et al., 2008). In agreement with this, we
observed in methylcellulose colony assays a Wnt dosage-
dependent increase in c-kit expression. This is also in agreement
with a block in differentiation observed after in vivo stabilization
of b-catenin (Kirstetter et al., 2006; Scheller et al., 2006).
Together with our results, these suggests that low levels of
Figure 7. Differential Optimum of Wnt Signaling
Strength in HSCs and Early Myeloid and T Cell
Progenitors
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Differential Wnt Signaling during HematopoiesisWnt signaling activation result in the maintenance of a multipo-
tent state, therefore resulting in increased reconstitution, and
that high Wnt activation results in impaired hematopoiesis par-
tially because of a block in differentiation.
Whereas HSCs in the BM show enhanced activity strictly with
mild levels of Wnt signaling, more differentiated progenitor/
precursor cells show advantage with a stronger activation of
the pathway, with myeloid differentiation being favored with
mild and intermediate Wnt signaling activation and early thymo-
cyte development having advantage only with intermediate
levels of Wnt activity (Figure 7). Enhanced myelopoiesis in vivo
occurred mainly in GMPs and immature CD11b+F4/80myeloid
progenitors, consistent with the higher Wnt reporter activity in
myeloid progenitor versus mature cells. Despite the observed
high Wnt activity in early B cell progenitors, B cell development
in vitro was not affected by any of the Wnt dosages (data not
shown), in agreement with our previous observations in which
Wnt3a deficiency affects only myeloid development but not B
lymphocyte development (Luis et al., 2009). In addition, no signs
of myeloid or precursor B cell leukemias were observed in mice
transplanted with Apc15lox/+ LSKs. Because of the absence of
reconstitution with intermediate and high level of Wnt signaling,
it cannot be excluded that higher Wnt activation would lead
to leukemia. Indeed, overexpression of constitutively activated
Lef1 in hematopoietic stem/progenitor cells, which should
lead to a high activation of the Wnt pathway, leads to the
development of B-lymphoblastic and acute myeloid leukemia
(Petropoulos et al., 2008).
Early thymocyte subsets showed an even stronger require-
ment for Wnt signaling. Canonical Wnt signaling was previously
shown to regulate the DN3 to DP transition during thymocyte
development (Gounari et al., 2001, 2005; Staal et al., 2001).
Lck-Cre-mediated stabilization of b-catenin, starting at DN2-
DN3 stages, results in impaired Tcrb rearrangements but
allowed thymocytes to progress to DN4, DP, and SP stages
without pre-TCR signaling, thus bypassing the b-selection
checkpoint. Accordingly, high levels of activation of the Wnt
pathway showed a comparable phenotype that was more
pronounced in the mice with the highest activation. Importantly,





/number of DN3 cells and in a burst of DN4
thymocytes with normal Tcrb expression. These
findings suggest that intermediate Wnt activity
enhances the immature stages (DN) of T cell
development while preserving physiological
processes such as TCR rearrangements and
maintaining developmental checkpoints. How-
ever, the numbers of DP cells and consequently
the total thymus cellularity in mice with inter-
mediate Wnt activity was still reduced, which
may indicate that later stages of T cell develop-
ment have different Wnt signaling requirements.
Wnt signaling also regulates aspects of negativeand positive selection and the DP to SP transition (Ioannidis
et al., 2001; Staal et al., 2008; Yu and Sen, 2007) and apparently
high Wnt levels are detrimental for these processes to occu
correctly in vivo. In agreement, in in vitro cocultures with OP9
stromal cells expressing the Notch ligand Delta1, where positive
and negative selection processes are less stringent (Dervovic
and Zu´n˜iga-Pflu¨cker, 2010), an increase in both DP and SP cells
with intermediate but not higher levels of Wnt activation was
observed. In addition, whereas early T cell development was
increased with intermediate Wnt activity, a milder Wnt activation
had no effect, in contrast to the HSC compartment and myeloid
differentiation in BM. Accordingly, mice transplanted with
Apc15lox/+ deleted HSCs did not show any differences in T cel
development. Together with previous studies on Tcf1/Lef1/
mice (Okamura et al., 1998), which show a complete thymocyte
differentiation arrest at the DN to DP transition, the results we
present here similarly demonstrate a high sensitivity for ‘‘just-
right’’ levels of Wnt signaling activity during the transition from
DN to DP stages of T cell development.
In addition to the genetically modifiedmousemodels tomodu-
lateWnt activation, Wnt signaling during hematopoietic develop-
ment can be studied with reporter mouse models (Barolo, 2006)
To date, several different in vivo Wnt reporter mice have been
described, each with slight differences and inherent limitations
especially relative to their detection and tissue-specific sensi-
tivity (Currier et al., 2010; DasGupta and Fuchs, 1999; Jho
et al., 2002; Lustig et al., 2002; Maretto et al., 2003; Moriyama
et al., 2007). In general, theseWnt reporter transgenes are based
onminimal promoters equippedwith amultimerized TCF binding
site driving expression of a marker cassette such as LacZ o
GFP. Differences in sensitivity and tissue specificity are though
to result from the variable number of TCF motifs (Biechele and
Moon, 2008), the employed promoter, but also by epigenetic
silencing of the transgenic sequences, cell cycle and differentia-
tion status, and other context-dependent inhibitory effects
(Barolo, 2006). In view of the broad spectrum of Wnt signaling
dosages analyzed in this study, we employed Axin2-LacZ
reporter mice (Lustig et al., 2002) known for their high detection
sensitivity and broad expression patterns. Indeed, the Axin2
Conductin gene represents one of the most reproducible and
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Differential Wnt Signaling during Hematopoiesisrobust Wnt downstream targets described to date. Moreover,
we validated the results obtained with the in vivo Wnt reporter
by qRT-PCR analysis of the endogenous Axin2 gene on three
‘‘Wnt-responsive’’ hematopoietic populations (Figure S6). In
fact, the levels of Wnt signaling detected with the Axin2-
LacZ reporter are likely to represent an underestimate of the
actual number of Wnt-responsive HSCs. Novel, more sensitive,
and direct detection methods (e.g., detection of intracellular
levels of active, i.e., dephosphorylated, b-catenin at residues
Ser37 and Thr41) (Staal et al., 2002) will be required to analyze
Wnt activity in hematopoietic populations that were scored as
negative in the reporter mouse in this study. Also, the Axin2-
reporter mouse was exclusively employed to study hematopoi-
esis in wild-type (i.e., Apc-proficient) animals, whereas, ideally,
it should have also been used in the Apc mutant background
during hematopoietic development. However, the complex
breeding patterns (four different transgenic alleles) prevented
us from conducting these experiments within the present study.
In the future, new, GFP-like-based in vivo reporter tools will be
needed to more precisely quantify the Wnt signaling level on
the single-cell level.
An alternative interpretation of our data is that the observed
consequences of different combinations of Apc mutant alleles
are not Wnt but rather Apc dependent. Although its major
tumor-suppressing function is known to reside in the capacity
to negatively regulate the canonical Wnt/b-catenin signaling
pathway, Apc does encode for a multifunctional protein
involved in a broad spectrum of cellular functions ranging from
cell adhesion and motility, organization of the actin and micro-
tubule networks, chromosomal segregation at mitosis, and cell
cycle regulation (Fodde, 2003). From this perspective, one
could argue that the effects on hematopoiesis result from the
interference with one or more functions of Apc rather than the
control of Wnt signaling. However, previous analyses of Apc
function indicate that this scenario is highly unlikely (Gaspar
and Fodde, 2004). To date, most Apc-mutant mouse models
are characterized by tumor phenotypes, the organ specificity
and severity of which depend on Wnt signaling dosage.
Apc1638T, the only targeted Apc mutation that does not affect
Wnt signaling, results in homozygous viable and tumor-free
animals, notwithstanding the deletion of the C-terminal third of
the protein containing the above mentioned functional domains
(Smits et al., 1999). Deletion of only a few amino acids encom-
passing crucial Axin-binding motifs from the C terminus of
Apc1638T results in Wnt signaling activation and tumor formation.
Finally, mutations affecting other members of the Wnt pathway
like Gsk3b and b-catenin result in levels of signaling activation
and hematopoietic defects that are fully in agreement with our
results, as discussed above. Hence, we conclude that the
most likely explanation is that specific levels of Wnt signaling
are the major determinant of the observed differential effects
on hematopoiesis.
In conclusion, we report differential Wnt signaling effects and
optimum levels of activity in HSCs, myeloid progenitors, and
early T cell progenitors (Figure 7). In APC-driven tumorigenesis
in both mouse and man (Albuquerque et al., 2002; Smits et al.,
2000), ‘‘just-right’’ levels of Wnt/b-catenin signaling are selected
to provide advantages to nascent tumor cells in a context- and
dosage-dependent fashion. Our results indicate that the same354 Cell Stem Cell 9, 345–356, October 7, 2011 ª2011 Elsevier Inc.is true for normal hematopoiesis. It is well documented that
morphogens like Wnt proteins determine different cell fates
through concentration gradients that modulate basic cellular
processes during development. We speculate that this also
holds true for a strictly regulated process like hematopoietic
development. The different cellular environments where hemato-
poiesis occur, e.g., the regions inside the thymus through which
thymocytes migrate during T cell development, are likely to
provide different environmental signals that can vary in type,
strength, and duration of the signals, to ensure that different
processes happen in the correct order and time. Such consider-
ations are of great relevance toward the translation of basic
findings on the molecular and cellular mechanisms underlying
the regulation of hematopoiesis into clinical protocols for
ex vivo expansion of HSC or thymic reconstitution. These appli-
cations are likely to be significantly improved and tailored by
exposing cells to the just-right dosage of canonicalWnt signaling




A list of antibodies used to define the different hematopoietic subsets analyzed
is provided in the Supplemental Experimental Procedures. Stained cells were
measured with a FACS-Canto II or a LSRII, sorted on a FACS AriaII (Becton
Dickinson), and analyzed with FlowJO software (Treestar).
Retroviral Production and Transduction
MSCV-Cre-IRES-GFP plasmid was kindly provided by H. Nakauchi (Institute
of Medical Science, University of Tokyo, Japan) and viruses were generated
with the Phoenix-packaging cell line. 40,000–70,000 sorted LSKs were stimu-
lated overnight in serum-free medium (StemCell Technologies) supplemented
with cytokines (100 ng/ml rmSCF, 10 ng/ml rmTPO, and 50 ng/ml rmFlt3L;
from R&D) and transduced with titrated amounts of virus with Retronectin
(Takara Bio Inc.). Cells were cultured for 2 additional days and GFP+ cells
were sorted and used for in vitro and in vivo assays.
Competitive Transplantation Assays
Competitive transplantation assays were performed with the CD45.1/CD45.2
system. Specified numbers of sorted GFP+ LSKs from mice with the different
genotypes (CD45.2) were transplanted into lethally irradiated (9.5Gy) CD45.1
(9–12 weeks) mice together with 1.5 3 105 CD45.1 bone marrow competitor
cells and 5 3 105 CD45.1 spleen support cells. Chimerism was analyzed at
4, 8, and 12 weeks after transplantation in peripheral blood, and mice were
sacrificed for analysis at 12 weeks posttransplantation. Mice were considered
repopulated whenR1%multilineage CD45.1 cells could be detected in nucle-
ated peripheral blood cells 3months after transplantation. Calculation of CRUs
was conducted with L-Calc software (StemCell Technologies).
Methylcelulose Colony-Forming Assays
Sorted GFP+ cells were cultured in MethoCult M3434 (containing 50 ng/mL
rmSCF, 10 ng/mL rmIL-3, 10 ng/mL rhIL-6, 3 U/mL rhEPO; from StemCell
Technologies) supplemented with 20 ng/ml rmTPO (R&D). All assays were
done in triplicate. Colonies (>30 cells) were counted after 9–10 days. CFU-
Mix was defined as colonies containing at least three different cell types.
Colonies were identified by morphology and confirmed with May-Grunwald
Giemsa staining.
Coculture of LSK Cells with OP9 Stromal Cell Lines
5,000 sorted GFP+ LSKs were cultured on confluent layers of OP9-GFP or
OP9-DL1 cells, with 50 ng/ml rmSCF, 5 ng/ml rmFlt3L, and 20 ng/ml rmIL-7
(all cytokines from R&D). After 14 days of culture, cells were harvested and
stained for flow cytometry analysis.
Cell Stem Cell
Differential Wnt Signaling during HematopoiesisStatistical Analysis
Statistical significance was determined by standard t test. Limiting-dilution
transplantation assays were analyzed with L-Calc software (StemCell
Technologies).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
doi:10.1016/j.stem.2011.07.017.
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